Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		95,868,421
Beginning balance at Dec. 31, 2023	$ 123,139	$ 9	$ 602,198	$ (479,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(1,403)			(1,403)
Stock options exercised (in shares)		126,000
Stock options exercised	508		508
Stock-based compensation	2,523		2,523
Vested restricted stock units (in shares)		1,174,282
Ending balance (in shares) at Mar. 31, 2024		97,168,703
Ending balance at Mar. 31, 2024	124,767	$ 9	605,229	(480,471)
Beginning balance (in shares) at Dec. 31, 2023		95,868,421
Beginning balance at Dec. 31, 2023	123,139	$ 9	602,198	(479,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(5,314)
Ending balance (in shares) at Sep. 30, 2024		101,203,839
Ending balance at Sep. 30, 2024	133,868	$ 10	618,241	(484,383)
Beginning balance (in shares) at Mar. 31, 2024		97,168,703
Beginning balance at Mar. 31, 2024	124,767	$ 9	605,229	(480,471)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(4,077)			(4,077)
Stock-based compensation	8,905		8,905
Vested restricted stock units (in shares)		2,924,878
Shares issued under employee stock purchase plan (in shares)		63,393
Shares issued under employee stock purchase plan	86		86
Ending balance (in shares) at Jun. 30, 2024		100,156,974
Ending balance at Jun. 30, 2024	129,681	$ 9	614,220	(484,548)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	165			165
Stock options exercised (in shares)		460,000
Stock options exercised	1,856		1,856
Stock-based compensation	2,166		2,166
Vested restricted stock units (in shares)		586,865
Vested restricted stock	0	$ 1	(1)
Ending balance (in shares) at Sep. 30, 2024		101,203,839
Ending balance at Sep. 30, 2024	$ 133,868	$ 10	618,241	(484,383)
Beginning balance (in shares) at Dec. 31, 2024	109,159,697	109,159,697
Beginning balance at Dec. 31, 2024	$ 174,307	$ 11	659,488	(485,192)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	3,254			3,254
Stock options exercised (in shares)		75,000
Stock options exercised	384		384
Stock-based compensation	2,412		2,412
Vested restricted stock units (in shares)		1,253,999
Ending balance (in shares) at Mar. 31, 2025		110,488,696
Ending balance at Mar. 31, 2025	$ 180,357	$ 11	662,284	(481,938)
Beginning balance (in shares) at Dec. 31, 2024	109,159,697	109,159,697
Beginning balance at Dec. 31, 2024	$ 174,307	$ 11	659,488	(485,192)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ 7,883
Stock options exercised (in shares)	75,000
Ending balance (in shares) at Sep. 30, 2025	112,123,757	112,123,757
Ending balance at Sep. 30, 2025	$ 190,185	$ 11	667,484	(477,310)
Beginning balance (in shares) at Mar. 31, 2025		110,488,696
Beginning balance at Mar. 31, 2025	180,357	$ 11	662,284	(481,938)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	3,870			3,870
Stock-based compensation	2,716		2,716
Vested restricted stock units (in shares)		1,093,352
Shares issued under employee stock purchase plan (in shares)		18,189
Shares issued under employee stock purchase plan	85		85
Ending balance (in shares) at Jun. 30, 2025		111,600,237
Ending balance at Jun. 30, 2025	187,028	$ 11	665,085	(478,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	758			758
Stock-based compensation	$ 2,399		2,399
Vested restricted stock units (in shares)		523,520
Ending balance (in shares) at Sep. 30, 2025	112,123,757	112,123,757
Ending balance at Sep. 30, 2025	$ 190,185	$ 11	$ 667,484	$ (477,310)